BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alghamri MS, McClellan BL, Hartlage MS, Haase S, Faisal SM, Thalla R, Dabaja A, Banerjee K, Carney SV, Mujeeb AA, Olin MR, Moon JJ, Schwendeman A, Lowenstein PR, Castro MG. Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments. Front Pharmacol 2021;12:680021. [PMID: 34084145 DOI: 10.3389/fphar.2021.680021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Liao Y, Liu B, Jin C, Liao X, Zhang Z. Exploring the Correlation of Abnormal CXCL9 Expression with Immune Infiltration in Glioma and Patient Prognosis Based on TCGA and GTEx Databases. J Mol Neurosci 2022. [DOI: 10.1007/s12031-022-02083-x] [Reference Citation Analysis]
2 Quach S, Holzgreve A, Kaiser L, Unterrainer M, Dekorsy FJ, Nelwan DV, Bartos LM, Kirchleitner SV, Weller J, Weidner L, Niyazi M, Ruf VC, Herms J, Stöcklein S, Wetzel C, Riemenschneider MJ, v. Baumgarten L, Thon N, Brendel M, Rupprecht R, Bartenstein P, Tonn J, Albert NL. TSPO PET signal using [18F]GE180 is associated with survival in recurrent gliomas. Eur J Nucl Med Mol Imaging 2022. [DOI: 10.1007/s00259-022-06006-1] [Reference Citation Analysis]
3 Pauwels MJ, Xie J, Ceroi A, Balusu S, Castelein J, Van Wonterghem E, Van Imschoot G, Ward A, Menheniott TR, Gustafsson O, Combes F, El Andaloussi S, Sanders NN, Mäger I, Van Hoecke L, Vandenbroucke RE. Choroid plexus-derived extracellular vesicles exhibit brain targeting characteristics. Biomaterials 2022;290:121830. [DOI: 10.1016/j.biomaterials.2022.121830] [Reference Citation Analysis]
4 Chevaleyre C, Kereselidze D, Caillé F, Tournier N, Olaciregui NG, Winkeler A, Declèves X, Jego B, Cisternino S, Auvity S, Truillet C. TSPO PET Imaging as a Potent Non-Invasive Biomarker for Diffuse Intrinsic Pontine Glioma in a Patient-Derived Orthotopic Rat Model. IJMS 2022;23:12476. [DOI: 10.3390/ijms232012476] [Reference Citation Analysis]
5 Faisal SM, Comba A, Varela ML, Argento AE, Brumley E, Abel C, Castro MG, Lowenstein PR. The complex interactions between the cellular and non-cellular components of the brain tumor microenvironmental landscape and their therapeutic implications. Front Oncol 2022;12:1005069. [DOI: 10.3389/fonc.2022.1005069] [Reference Citation Analysis]
6 Franson A, Mcclellan BL, Varela ML, Comba A, Syed MF, Banerjee K, Zhu Z, Gonzalez N, Candolfi M, Lowenstein P, Castro MG. Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment. Front Med 2022;9. [DOI: 10.3389/fmed.2022.966458] [Reference Citation Analysis]
7 Parasar P, Kaur N, Poisson LM, Singh J. X-linked adrenoleukodystrophy patient fibroblast-iPSC-derived astrocytes reveal phenotype-specific metabolic, inflammatory, and microRNA alterations.. [DOI: 10.1101/2022.09.09.507263] [Reference Citation Analysis]
8 Li B, Rao L. Pump proton inhibitors display anti-tumour potential in glioma. Cell Prolif 2022;:e13321. [PMID: 35961680 DOI: 10.1111/cpr.13321] [Reference Citation Analysis]
9 Hassel B, Niehusmann P, Halvorsen B, Dahlberg D. Pro-inflammatory cytokines in cystic glioblastoma: A quantitative study with a comparison with bacterial brain abscesses. With an MRI investigation of displacement and destruction of the brain tissue surrounding a glioblastoma. Front Oncol 2022;12:846674. [DOI: 10.3389/fonc.2022.846674] [Reference Citation Analysis]
10 Raghava Kurup R, Oakes EK, Manning AC, Mukherjee P, Vadlamani P, Hundley HA. RNA binding by ADAR3 inhibits adenosine-to-inosine editing and promotes expression of immune response protein MAVS. J Biol Chem 2022;:102267. [PMID: 35850307 DOI: 10.1016/j.jbc.2022.102267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Maimaiti B, Mijiti S, Jiang T, Xie Y, Zhao W, Cheng Y, Meng H. Case Report: H3K27M-Mutant Glioblastoma Simultaneously Present in the Brain and Long-Segment Spinal Cord Accompanied by Acute Pulmonary Embolism. Front Oncol 2021;11:763854. [PMID: 35211394 DOI: 10.3389/fonc.2021.763854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Glassman PM, Nong J, Myerson JW, Zuluaga-ramirez V, Rodriguez-garcia A, Mukalel A, Omo-lamai S, Walsh LR, Kiseleva RY, Villa CH, Greineder CF, Kasner SE, Weissman D, Mitchell MJ, Muro S, Persidsky Y, Brenner JS, Muzykantov VR, Marcos-contreras OA. Targeted nanocarriers coopting pulmonary leukocytes for drug delivery to the injured brain.. [DOI: 10.1101/2022.02.04.479150] [Reference Citation Analysis]
13 Lambrou GI. Epigenetics and personalized medicine of brain cancer. Epigenetics in Precision Medicine 2022. [DOI: 10.1016/b978-0-12-823008-4.00017-2] [Reference Citation Analysis]
14 Cruz Flores VA, Menghani H, Mukherjee PK, Marrero L, Obenaus A, Dang Q, Khoutorova L, Reid MM, Belayev L, Bazan NG. Combined Therapy With Avastin, a PAF Receptor Antagonist and a Lipid Mediator Inhibited Glioblastoma Tumor Growth. Front Pharmacol 2021;12:746470. [PMID: 34630114 DOI: 10.3389/fphar.2021.746470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Roesler R, Dini SA, Isolan GR. Neuroinflammation and immunoregulation in glioblastoma and brain metastases: Recent developments in imaging approaches. Clin Exp Immunol 2021;206:314-24. [PMID: 34591980 DOI: 10.1111/cei.13668] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
16 Tseng CH. Metformin and Risk of Malignant Brain Tumors in Patients with Type 2 Diabetes Mellitus. Biomolecules 2021;11:1226. [PMID: 34439890 DOI: 10.3390/biom11081226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]